Schmidt David

SEC source: 0001104659-26-098353 · tm2623303-1_4seq1.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-26-098353 · tm2623303-1_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,019

F1 · kind: These shares were repurchased by the Issuer.

F2 · balance_after: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001104659-26-098353 · tm2623303-1_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,019

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-26-073493 · tm2617575-6_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,019

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

F2 · balance_after: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001104659-26-004091 · tm263273-1_4seq1.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2026-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-26-004091 · tm263273-1_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,494

F1 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001104659-26-004091 · tm263273-1_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-25-087027 · tm2525111-1_4seq1.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-25-087027 · tm2525111-1_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,763

F1 · kind: These shares were repurchased by the Issuer.

F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001104659-25-087027 · tm2525111-1_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-25-059361 · tm2517874-1_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,763

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.

F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001104659-24-090513 · tm2421838-1_4seq1.xml · nonDerivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,314

F1 · kind: These shares were repurchased by the Issuer.

F2 · balance_after: Includes 5,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

SEC source: 0001104659-24-090513 · tm2421838-1_4seq1.xml · derivative · entry 5

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,409 shares

Expires 2024-11-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-24-090513 · tm2421838-1_4seq1.xml · derivative · entry 4

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-24-090513 · tm2421838-1_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-090513 · tm2421838-1_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-089689 · tm2421691-2_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,314

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders.

F2 · balance_after: Includes 5,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

SEC source: 0001104659-23-126910 · tm2333076-8_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,750

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 5,750 shares of restricted stock, which will vest on December 9, 2024.

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were granted on January 11, 2019 and were fully vested and exercisable.

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were repurchased by the issuer.

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-22-000024 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

SEC source: 0001628280-21-017366 · wf-form4_162941358600004.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2023-05-21

F2 · derivative.exercise_date: These stock options were granted on May 21, 2013, vested and became exercisable evenly on a monthly basis over thirty six months commencing on June 1, 2013.

SEC source: 0001628280-21-017366 · wf-form4_162941358600004.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · acquired: These shares were sold to Allied Physicians of California, A Professional Medical Corp.

SEC source: 0001628280-21-017366 · wf-form4_162941358600004.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-20-000098 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2025-11-11

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from the option grant date.

SEC source: 0001104659-20-023832 · tm209648d6_4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,050

Underlying: Common Stock · 3,550 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023825 · tm209648-2_4a.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,500

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-046381 · tm2015807d4_4a.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,909

Underlying: Common Stock · 3,409 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001104659-19-075846 · tm1927354d1_4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,548

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-065782 · tm1923454d9_form4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001567619-19-001172 · doc1.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2023-12-31

F1 · derivative.exercise_date: The Issuer granted these options to Mr. Schmidt in consideration for his service as a director. They vest in 4 installments over one year quarterly on March 31, June 30, September 30 and December 31.

SEC source: 0001553350-19-000342 · ownership.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2024-01-11

F1 · derivative.exercise_date: This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020.

F1 · derivative.expiration_date: This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020.

SEC source: 0001498865-16-000011 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-02-14

F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016.

F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016.

SEC source: 0001498865-17-000002 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-09-14

F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016.